Literature DB >> 26740341

Improving the MR Imaging Sensitivity of Upconversion Nanoparticles by an Internal and External Incorporation of the Gd(3+) Strategy for in Vivo Tumor-Targeted Imaging.

Hongli Du, Jiani Yu1, Dongcai Guo, Weitao Yang2, Jun Wang1, Bingbo Zhang1.   

Abstract

Gd(3+)-ion-doped upconversion nanoparticles (UCNPs), integrating the advantages of upconversion luminescence and magnetic resonance imaging (MRI) modalities, are capturing increasing attention because they are promising to improve the accuracy of diagnosis. The embedded Gd(3+) ions in UCNPs, however, have an indistinct MRI enhancement owing to the inefficient exchange of magnetic fields with the surrounding water protons. In this study, a novel approach is developed to improve the MR imaging sensitivity of Gd(3+)-ion-doped UCNPs. Bovine serum albumin (BSA) bundled with DTPA-Gd(3+) (DTPA(Gd)) is synthesized both as the MR imaging sensitivity synergist and phase-transfer ligand for the surface engineering of UCNPs. The external Gd(3+) ion attachment strategy is found to significant improve the MR imaging sensitivity of Gd(3+)-ion-doped UCNPs. The relaxivity analysis shows that UCNPs@BSA·DTPA(Gd) exhibit higher relaxivity values than do UCNPs@BSA without DTPA(Gd) moieties. Another relaxivity study discloses a striking message that the relaxivity value does not always reflect the realistic MRI enhancement capability. The high concentration of Gd(3+)-ion-containing UCNPs with further surface-engineered BSA·DTPA(Gd) (denoted as UCNPs-H@BSA·DTPA(Gd)) exhibits a more pronounced MRI enhancement capability compared to the other two counterparts [UCNPs-N@BSA·DTPA(Gd) and UCNPs-L@BSA·DTPA(Gd) (-N and -L are denoted as zero and low concentrations of Gd(3+) ion doping, respectively)], even though it holds the lowest r1 of 1.56 s(-1) per mmol L(-1) of Gd(3+). The physicochemical properties of UCNPs are essentially maintained after BSA·DTPA(Gd) surface decoration with good colloidal stability, in addition to improving the MR imaging sensitivity. In vivo T1-weighted MRI shows potent tumor-enhanced MRI with UCNPs-H@BSA·DTPA(Gd). An in vivo biodistribution study indicates that it is gradually excreted from the body via hepatobiliary and renal processing with no obvious toxicity. It could therefore be concluded, with improved MR imaging sensitivity by an internal and external incorporation of Gd(3+) strategy, that UCNPs-H@BSA·DTPA(Gd) presents great potential as an alternative in tumor-targeted MR imaging.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26740341     DOI: 10.1021/acs.langmuir.5b04186

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  5 in total

1.  A Fibrous Localized Drug Delivery Platform with NIR-Triggered and Optically Monitored Drug Release.

Authors:  Heng Liu; Yike Fu; Yangyang Li; Zhaohui Ren; Xiang Li; Gaorong Han; Chuanbin Mao
Journal:  Langmuir       Date:  2016-08-24       Impact factor: 3.882

Review 2.  Nanoparticle Functionalization and Its Potentials for Molecular Imaging.

Authors:  Rukmani Thiruppathi; Sachin Mishra; Mathangi Ganapathy; Parasuraman Padmanabhan; Balázs Gulyás
Journal:  Adv Sci (Weinh)       Date:  2016-12-16       Impact factor: 16.806

Review 3.  Upconversion Nanoparticles for Bioimaging and Regenerative Medicine.

Authors:  María González-Béjar; Laura Francés-Soriano; Julia Pérez-Prieto
Journal:  Front Bioeng Biotechnol       Date:  2016-06-13

Review 4.  Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery.

Authors:  Fei-Fei An; Xiao-Hong Zhang
Journal:  Theranostics       Date:  2017-08-23       Impact factor: 11.556

Review 5.  Recent progress in the development of upconversion nanomaterials in bioimaging and disease treatment.

Authors:  Gaofeng Liang; Haojie Wang; Hao Shi; Haitao Wang; Mengxi Zhu; Aihua Jing; Jinghua Li; Guangda Li
Journal:  J Nanobiotechnology       Date:  2020-10-29       Impact factor: 10.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.